James M. Daly

James M. Daly has served as a Director argenx since May 2018. Mr. Daly is a biopharmaceutical executive with 30 years of experience leading U.S. and global businesses. He was most recently the Chief Commercial Officer of Incyte, a publicly traded oncology and inflammation company. Prior to this, Mr. Daly he held multiple leadership positions at Amgen, including his last role as Senior Vice President for North America Commercial Operations.

Before Amgen, he was at GlaxoSmithKline for nearly 17 years where he held various positions in both the U.S. and abroad, including Senior Vice President of the Respiratory Division with responsibility for sales, marketing and medical affairs. Mr. Daly currently serves as a Director of Acadia Pharmaceuticals, Halozyme Therapeutics and Bellicum Pharmaceuticals. He holds a Bachelor of Science and a Master of Business Administration from the University of Buffalo at New